Gelonghui, January 9丨Guangshengtang (300436.SZ) announced that in order to implement the company's internationalization strategy, expand the international business field of the company's drugs, especially anti-coronavirus drugs, promote the development and growth of the international business scale and further enhance the company's comprehensive strength, Fujian Guangshengtang Pharmaceutical Co., Ltd. plans to jointly invest in the establishment of the relevant party Fuzhou Aotai Phase 9 Investment Partnership (Limited Partnership) (“Aotai Phase 9”) (“Aotai Phase 9” for short). Guangfulai's registered capital is RMB 50 million, of which the company plans to invest 35 million yuan in monetary form, accounting for 70% of Guangfulai's registered capital; Aotai Phase IX plans to invest 15 million yuan in monetary form, accounting for 30% of Guangfulai's registered capital.
广生堂(300436.SZ)：拟设立出口业务控股子公司广福来
Guangshengtang (300436.SZ): Proposes to establish Guang Fulai, a holding subsidiary for export business
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.